OneMedNet Corp
OneMedNet provides clinical image exchange and curated imaging Real World Data to healthcare providers and life sciences organizations, including pharmaceutical companies, artificial intelligence developers, medical device businesses and clinical research organizations. Its iRWD offering gives partners access to de-identified clinical images and associated patient records selected and curated to meet research and regulatory protocols. Its earlier BEAM product supports image exchange among healthcare providers. OneMedNet indexes data across a federated network of healthcare sites and uses an in-house clinical team to curate it; data remains onsite until specific de-identified information is licensed for a research opportunity. The company makes money by licensing this data to life science partners, while providers can receive income from sharing de-identified data. Its network includes 2,130 healthcare sites.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
OneMedNet Corp (ONMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook MINNEAPOLIS, NOVEMBER 6, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provi
OneMedNet (Nasdaq: ONMD) expects $1M in Q3 revenue, up 242% from Q2, and forecasts $12M-$14M for Q4. The company attributes growth to its healthcare data platform and scaled delivery infrastructure, according to its CEO.
OneMedNet (ONMD) announced a mid six-figure re-order from a foundation model company for radiology AI training data. The order expands a previous agreement and highlights demand for full-fidelity, de-identified medical imaging data. OneMedNet's data is sourced from over 2,300 healthcare partners and is used for training advanced AI models. The company's CEO noted the repeat order reflects customer satisfaction with data quality and scale.
Over the past 7 days, AlphAI's AI scored 7 news stories mentioning ONMD (OneMedNet Corp). Coverage has skewed bullish: 6 bullish, 1 neutral, and 0 bearish.
Recent ONMD coverage spans financial news, earnings and technology.
In the last 30 days, ONMD insiders filed 2 SEC Form 4 transactions — 2 purchases ($1000K) and no sales. The most active reporter was Kosasa Thomas with 1 filing.
Guidance suggests strong revenue growth quarter‑over‑quarter
Guidance suggests rapid revenue growth, which may lift the stock if expectations were lower.
The repeat order adds incremental revenue and validates OneMedNet's data quality, likely supporting a modest positive price move.
The follow-on add-on order suggests accelerating customer demand for OneMedNet’s regulatory-grade RWD and potential recurring sublicensing revenue.
The partnership expands OneMedNet's market reach and could boost revenue growth.
AlphAI scores every news story that mentions ONMD with an AI model for sentiment and relevance, and aggregates insider trades from OneMedNet Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
OneMedNet Corp (ONMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook MINNEAPOLIS, NOVEMBER 6, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provi
OneMedNet (Nasdaq: ONMD) expects $1M in Q3 revenue, up 242% from Q2, and forecasts $12M-$14M for Q4. The company attributes growth to its healthcare data platform and scaled delivery infrastructure, according to its CEO.
OneMedNet (ONMD) announced a mid six-figure re-order from a foundation model company for radiology AI training data. The order expands a previous agreement and highlights demand for full-fidelity, de-identified medical imaging data. OneMedNet's data is sourced from over 2,300 healthcare partners and is used for training advanced AI models. The company's CEO noted the repeat order reflects customer satisfaction with data quality and scale.
OneMedNet (ONMD) received a high six-figure add-on order from a customer under a multiyear agreement, exercising an expansion option to increase data volume. The customer uses the data to build and sell a derivative dataset. The company attributes the repeat order to the speed, quality, and depth of its data, sourced from over 2,300 healthcare partners. The deal includes potential recurring sublicensing revenue for OneMedNet.
OneMedNet (Nasdaq: ONMD) announced a 12th channel partner agreement to distribute its U.S. medical data to global drug companies. The deal expands its reach in the growing pharmaceutical data market. OneMedNet's data is sourced directly from healthcare providers and is de-identified at the source. The company's CEO highlighted the quality and compliance of their data.
OneMedNet Corporation (Nasdaq: ONMD) announced a new hospital system partnership, expanding its iRWD™ platform and federated provider network. The addition enhances the depth and scale of its healthcare data, capturing complete patient journeys. The company expects to add up to 12 more hospitals, strengthening its position in AI-driven real-world data for healthcare innovation and regulatory submissions.
GameStop CEO Ryan Cohen bought 700,000 shares for $17.1M at $24.41 each, now trading at $27.23. Innovative Industrial Properties' chairman bought $1M in preferred stock. OneMedNet saw two insiders buy shares. Grace Therapeutics' director bought shares. Talos Energy, Sharplink, Arista Networks, Hinge Health, and Workday saw insider sales.
OneMedNet (ONMD) has regained compliance with Nasdaq's $1.00 minimum bid price requirement. The company met the requirement with 10 consecutive business days of closing prices at or above $1.00, ending October 12, 2026. Nasdaq confirmed compliance on October 13, 2026.
OneMedNet Corp (ONMD) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. As previously disclosed, on April 14, 2026, OneMedNet Corporation (the “Company”) received a letter from the staff of the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it was not in compli
Kosasa Thomas, a 10% owner and director of OneMedNet, bought 129,758 shares at $5.78 each, totaling $750,001 on October 7, 2026. Post-purchase, they own 1,983,573 shares. The price was based on the 10-day VWAP prior to the transaction, according to an SEC filing.
